NICE recommended personalised immunotherapy to treat blood cancer in children and young adults to be made routinely available on the NHS
Innovative CAR-T therapy recommended to treat an aggressive form of leukaemia.
Innovative CAR-T therapy recommended to treat an aggressive form of leukaemia.
People could be offered a genetic test in the immediate period after having a stroke to help identify the most suitable treatment to reduce their risk of further strokes.
New one-a-day pill recommended on the same day the treatment was granted a licence by the MHRA.
NICE does not recommend Enhertu (also called trastuzumab deruxtecan and made by Daiichi Sankyo) for treating advanced HER2-low breast cancer in adults.
A new treatment option given with chemotherapy is recommended for some types of advanced or recurrent womb cancer in final draft NICE guidance published today.
The consultation seeks your views about our plans to make topic selection and prioritisation more integrated, effective and timely.
Page 15 of 39